Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report

Warkentin TE, Kelton JG (1996) A 14-year study of heparin-induced. Am J Med 101(5):502–507 Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344(17):1286–1292 Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P (2005 Jul) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective of 408 patients. Thromb Haemost 94(1):132–135 Greinacher A (2015) Heparin-induced thrombocytopenia. N Engl J Med 373(3):252–261 Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE (2017) Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review. Platelets 28(6):614–620 Nguyen TH, Medvedev N, Delcea M, Greinacher A (2017) Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity. Nat Commun 8(May):1–12 Warkentin TE (2016) Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. Thromb Haemost 116(5):813–822 Warkentin TE, Sheppard JAI, Horsewood P, Simpson PJ, Moore JC, Kelton JG (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96(5):1703–1708 Chaudhry R, Wegner R, Zaki JF, Pednekar G, Tse A, Kukreja N et al (2017) Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing vascular surgery. J Cardiothorac Vasc Anesth 31(5):1751–1757 Warkentin TE, Roberts RS, Hirsh J, Kelton JG (2003) An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 163(20):2518–2524 Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM et al (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103(14):1838–1843 Greinacher A, Völpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P et al (1999) Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 99(1):73–80 Warkentin TE, Kelton JG (2001) Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135(7):502 Mian H, Warkentin TE, Sheppard JAI, MacDonald A, Linkins LA, Benger A et al (2017) Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma. Blood 130:1679–1682 Warkentin TE, Sheppard JAI, Manheim JC (2014) HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT. Thromb Haemost 112:1319–1322 Warkentin TE, Basciano PA, Knopman J, Bernstein RA (2014) Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. Blood 123(23):3651–3654 Greinacher A, Selleng K, Warkentin TE (2017) Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost 15(11):2099–2114 Warkentin TE, Heddle NM (2003) Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2:148–157 Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG (2008) Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost 6(8):1304–1312 Cuker A (2014) Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost 40(1):106–114 Warkentin TE (2019) Laboratory diagnosis of heparin-induced thrombocytopenia. Int J Lab Hematol 41(S1):15–25 Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67(1):27–30 Stewart MW, Etches WS, Boshkov LK, Gordon PA (1995) Heparin-induced thrombocytopenia: an improved method of detection based on lumi‐aggregometry. Br J Haematol 91(1):173–177 Frame JN, Mulvey KP, Phares JC, Anderson MJ (1989) Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. Ann Intern Med 111(11):946–947 Warkentin TE (2019) High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol 12(8):685–698 Tvito A, Bakchoul T, Rowe JM, Greinacher A, Ganzel C (2015) Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment. Am J Hematol 90(7):675–678 Park BD, Kumar M, Nagalla S, De Simone N, Aster RH, Padmanabhan A et al (2018) Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia. Transfus Apher Sci 57:561–565 Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C (1994 May) Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation–a possible new indication for high dose i.v. IgG. Thromb Haemost 71(5):641–645 Arcinas LA, Manji RA, Hrymak C, Dao V, Sheppard JAI, Warkentin TE (2019) Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin. Transfusion 59(6):1924–1933 Stiehm ER (2013 Jul) Adverse effects of human immunoglobulin therapy. Transfus Med Rev 27(3):171–178 Doucette K, DeStefano CB, Jain NA, Cruz AL, Malkovska V, Fitzpatrick K (2017) Treatment of refractory delayed onset heparin-induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG). Res Pract Thromb Haemost 1(1):134–137